Filter
821
Text search:
Dispensing
Featured
97
265
Language
Document type
407
164
139
47
31
21
5
5
1
1
Countries / Regions
48
43
43
35
34
27
26
22
19
19
18
16
15
13
13
11
10
10
10
8
8
8
7
7
6
6
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
445
41
35
27
19
15
9
Toolboxes
109
81
75
41
35
22
17
12
10
9
7
5
4
4
3
3
3
3
3
2
2
1
1
1
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was
...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Extract from "Essentials of Pharmaceutical Practice - EPP Handbook" by Ecumenical Pharmaceutical Network (EPN) (ISBN 978-9966-094-44-5). Chapter contents: Definition and understanding about SOPs - Importance of SOPs - Role of SOPs in ensuring quality of services in the pharmacy - Developing SOPs fo
...
Transforming the Quality of Health Care in Ethiopia
Standard Treatment Guideline
Course contents: What is Leprosy? Leprosy is a disease caused by a micro-organism called Mycobacterium leprae
Christian Connections for International Health (CCIH), a U.S.-
based nonprofit membership organization commissioned a
Family Planning (FP) survey of faith-based facility-based private
not-for-profit (FB-PNFP) health facilities in Uganda in 2013.
Country-wide health facilities of the Uganda Ortho
...
This manual describes some of the strategic, managerial, financial, technical and scientific aspects to be considered in establishing a national EQA programme for clinical laboratories and other testing services at all health care levels
Global Action Plan on Antimicrobial Resistance
recommended
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.
